| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/30/2008 | WO2008059368A3 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer |
| 10/30/2008 | WO2008052126A3 Ointment comprising phosphatidylserine as active agent for cancer treatment |
| 10/30/2008 | WO2008013987A3 N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones |
| 10/30/2008 | WO2007125210A3 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 10/30/2008 | WO2007114926A3 Kinase antagonists |
| 10/30/2008 | US20080271167 for treatment of viral infection and nervous systtem disorders |
| 10/30/2008 | US20080269511 Antitumor agents; synthetic derivatives equivalent to marine polyketide derived components isolated from bryozoan Myriapora truncata |
| 10/30/2008 | US20080269487 6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline; prevent, treat tumours which are sensitive to inhibition of erbB receptor tyrosine kinases |
| 10/30/2008 | US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes |
| 10/30/2008 | US20080269320 Cocoa Extracts |
| 10/30/2008 | US20080269319 Biologically active taxane analogs and methods of treatment |
| 10/30/2008 | US20080269309 Phosphoinositide-dependent kinase-1 (PDK-1) inhibitors; for the treatment and prevention of cancer in humans; 4-[5-(2-Phenanthracenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenecarboxamide |
| 10/30/2008 | US20080269304 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 10/30/2008 | US20080269298 anticarcinogenic agent, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; for treatment of susceptible neoplasm selected from breast, colon, lung, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma, ovarian, pancreatic, head and neck |
| 10/30/2008 | US20080269294 Benzamide Compounds Useful as Histone Deacetylase Inhibitors |
| 10/30/2008 | US20080269292 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them |
| 10/30/2008 | US20080269272 Anticancer agents; psoriasis; prevent activation of hedgehog gene passageways |
| 10/30/2008 | US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders |
| 10/30/2008 | US20080269266 Moderation of insulin-like growth factor receptors; anticancer agents |
| 10/30/2008 | US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas |
| 10/30/2008 | US20080269261 Combination of Zd6474 and Pemetrexed |
| 10/30/2008 | US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease |
| 10/30/2008 | US20080269259 Regulation of Autophagy and Cell Survival |
| 10/30/2008 | US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives |
| 10/30/2008 | US20080269254 Antiproliferative agents; anticancer agents; graft versus host disease; rheumatic diseases; vision defects; cardiovascular disorders |
| 10/30/2008 | US20080269238 Thiazolopyrimidine Derivative |
| 10/30/2008 | US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group |
| 10/30/2008 | US20080269234 Such as 7-((cyclohexyl)methyl) pyrido(2,3-d )pyridazine-4(5H)-one; anticancer agents; antiinflammatory agents;antiischemic agents; antidiabetic agents |
| 10/30/2008 | US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation |
| 10/30/2008 | US20080269218 using a triazole compound; anticancer agent |
| 10/30/2008 | US20080269215 Bisamide Inhibitors of Hedgehog Signaling |
| 10/30/2008 | US20080269210 Using 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimifin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfony)ethanone; lipid kinase inhibitor; anticancer agents |
| 10/30/2008 | US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide |
| 10/30/2008 | US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders |
| 10/30/2008 | US20080269201 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents |
| 10/30/2008 | US20080269193 Inhibition of heat shock protein diseases; antiproliferative agents; antiarthritic agents; antiinflammatory agents; autoimmune diseases; stroke; antiischemic agents; cardiovascular disorders; antitumor agents; anticancer agenst |
| 10/30/2008 | US20080269192 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds |
| 10/30/2008 | US20080269191 Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases |
| 10/30/2008 | US20080269189 Method for Avoiding Edema in the Treatment or Prevention of Ppary-Responsive Diseases, Including Cancer |
| 10/30/2008 | US20080269185 Methods Of Treating Oral Mucositis |
| 10/30/2008 | US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof |
| 10/30/2008 | US20080269170 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors |
| 10/30/2008 | US20080269169 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 10/30/2008 | US20080269163 Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis |
| 10/30/2008 | US20080269149 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease |
| 10/30/2008 | US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene |
| 10/30/2008 | US20080269144 Synthesis of Inhibitors of P90Rsk |
| 10/30/2008 | US20080269142 Endogenous thiadiazabicyclo glutathione-adduct |
| 10/30/2008 | US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof |
| 10/30/2008 | US20080269135 Method of treatment for early stage cancer |
| 10/30/2008 | US20080269133 Compositions and methods of use of epb1, and erbb3 binding protein |
| 10/30/2008 | US20080269131 Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis |
| 10/30/2008 | US20080269129 Polypeptide and dna thereof useful as a neovascular marker |
| 10/30/2008 | US20080269128 Albumin Fusion Proteins |
| 10/30/2008 | US20080269127 Albumin Fusion Proteins |
| 10/30/2008 | US20080269126 Albumin Fusion Proteins |
| 10/30/2008 | US20080269125 Albumin Fusion Proteins |
| 10/30/2008 | US20080269120 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 10/30/2008 | US20080269113 P53 binding t cell receptor molecules |
| 10/30/2008 | US20080269107 Treatment of mammalian cancers by the administration of HOXB4 protein and/or the overexpression of HOXB4 nucleotide sequence in order to induce apoptosis or otherwise decrease the survival of the target cancer cells |
| 10/30/2008 | US20080268073 derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, Rutaceae, Laminariaceae, Myrtaceae and Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor |
| 10/30/2008 | US20080268068 methods and kits for determining the presence or absence of a SPARC promoter mutation indicative of a cancer's resistance or sensitivity to a therapeutic regimen |
| 10/30/2008 | US20080268061 injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer; release of the therapeutically active substances is caused, initiated or substantially enhanced by an alternating magnetic field |
| 10/30/2008 | US20080268045 Sustained release methotrexate formulations and methods of use thereof |
| 10/30/2008 | US20080268041 Composition of 11 beta -(4-acetylphenyl)-17 beta -hydroxy-17 alpha -(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one and Tamoxifen; inhibits growth of breast cells |
| 10/30/2008 | US20080268040 Organic Compounds Comprising a Glycopyrrolium Salt |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/30/2008 | US20080267981 Treating neoplastic diseases with antibody-cytotoxin conjugate (duocarmycins); integrins; 3-[5-(1-(3-aminopropyl)indole-2-carbonyl)aminoindole-2-carbonyl]-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole |
| 10/30/2008 | US20080267980 Complement Receptor 2 Targeted Complement Modulators |
| 10/30/2008 | US20080267979 Heparan sulfate proteoglycan specific immunoglobulin for use in treatment and prevention of liver cancers |
| 10/30/2008 | US20080267978 Using alpha 2 beta 1 integrin specific immunoglobulin for prevention, diagnosis and treatment of cell proliferative disorders |
| 10/30/2008 | US20080267977 Combined immunological agent and sensitizing agent for the treatment of cancer |
| 10/30/2008 | US20080267976 Optimized Anti-Cd30 Antibodies |
| 10/30/2008 | US20080267972 Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer |
| 10/30/2008 | US20080267968 Using cocktail comprising endothelial growth factor specific immunoglobulin and chemotherapeutic agent to treat and/or prevent cervical cancer |
| 10/30/2008 | US20080267963 Administering individual an antigen-liposome preparation to treat and prevent cell proliferative disorders |
| 10/30/2008 | US20080267962 Albumin Fusion Proteins |
| 10/30/2008 | US20080267960 Methods of treating neoplastic, autoimmune and inflammatory diseases |
| 10/30/2008 | US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders |
| 10/30/2008 | US20080267957 Combination cancer therapy |
| 10/30/2008 | US20080267953 Anti-perp recombinant antibody |
| 10/30/2008 | US20080267951 Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling |
| 10/30/2008 | US20080267945 Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents |
| 10/30/2008 | US20080267935 Using mixture comprising cytosine arabinoside (AraC) and granulocyte macrophage colony stimulating factor immunotherapeutic to treat cell proliferative disorders; antitumor agents |
| 10/30/2008 | US20080267912 Novel inhibitors of glutaminyl cyclase |
| 10/30/2008 | US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea |
| 10/30/2008 | US20080267905 Antiinflammatory; angiogenesis inhibitors; synergistic; kits |
| 10/30/2008 | US20080267903 Cationic polyamines and dendrimeric polymers; anti-proliferative agents; for treatment of neoplasms and tumours, inflammatory disorders, autoimmune disorders, psoriasis, and atherosclerosis; gene therapy |
| 10/30/2008 | US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer |
| 10/30/2008 | US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment |
| 10/30/2008 | US20080267864 Cancerous disease modifying antibodies |
| 10/30/2008 | US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer |
| 10/30/2008 | US20080267862 Method of treating cancer |
| 10/30/2008 | CA2721739A1 Drug combination and its use in the treatment of muscle loss |
| 10/30/2008 | CA2685278A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 10/30/2008 | CA2685182A1 Osteopontin functional epitopes, monoclonal antibody against the epitopes and uses thereof |
| 10/30/2008 | CA2684950A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 10/30/2008 | CA2684949A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 10/30/2008 | CA2684749A1 Enzymatic anticancer therapy |
| 10/30/2008 | CA2684741A1 Low calcemic, highly antiproliferative, analogs of calcitriol |